Drugs / Octogam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02269163 Comparator | Jan 2016 → Jan 2019 | immunodeficiency disease | Prometic Biotherapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Octogam | “Gammargard, Gammaplex, Gamunex, or Octogam IGIV Product” NCT02269163 ↗ |
| Route | Intravenous | “Gammargard, Gammaplex, Gamunex, or Octogam IVIG Product” NCT02269163 ↗ |